Search research articles
Contact Us
Filters
Showing results (111-120 of 206) with videos related to
Page
of 21
Sort By:
Journal of the American College of Cardiology
|
September 6, 2005
Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study
Fernando Alfonso, José M Augé, Javier Zueco, et al.
International Journal of Cardiology
|
September 4, 2017
Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial
Shahar Lavi, Javaid Iqbal, John A Cairns, et al.
Circulation. Cardiovascular Interventions
|
March 9, 2021
Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial
Chao Gao, Norihiro Kogame, Faisal Sharif, et al.
Journal of the American College of Cardiology
|
October 16, 2007
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Dominick J Angiolillo, Esther Bernardo, Manel Sabaté, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 29, 2006
Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel
Dominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
JACC. Cardiovascular Interventions
|
January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials
Marco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
JAMA
|
April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial
Marco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Journal of the American College of Cardiology
|
June 6, 2006
Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial
Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions
|
April 7, 2018
The Presence of a CTO in a Non-Infarct-Related Artery During a STEMI Treated With Contemporary Primary PCI Is Associated With Increased Rates of Early and Late Cardiovascular Morbidity and Mortality: The CTO-TOTAL Substudy
Usaid K Allahwala, Sanjit S Jolly, Vladimír Džavík, et al.
Platelets
|
November 28, 2006
Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease
Esther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 206) with videos related to
Sort By:
Page
of 21
Journal of the American College of Cardiology
|
September 6, 2005
Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study
Fernando Alfonso, José M Augé, Javier Zueco, et al.
International Journal of Cardiology
|
September 4, 2017
Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial
Shahar Lavi, Javaid Iqbal, John A Cairns, et al.
Circulation. Cardiovascular Interventions
|
March 9, 2021
Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial
Chao Gao, Norihiro Kogame, Faisal Sharif, et al.
Journal of the American College of Cardiology
|
October 16, 2007
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Dominick J Angiolillo, Esther Bernardo, Manel Sabaté, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 29, 2006
Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel
Dominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
JACC. Cardiovascular Interventions
|
January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials
Marco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
JAMA
|
April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial
Marco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Journal of the American College of Cardiology
|
June 6, 2006
Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial
Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions
|
April 7, 2018
The Presence of a CTO in a Non-Infarct-Related Artery During a STEMI Treated With Contemporary Primary PCI Is Associated With Increased Rates of Early and Late Cardiovascular Morbidity and Mortality: The CTO-TOTAL Substudy
Usaid K Allahwala, Sanjit S Jolly, Vladimír Džavík, et al.
Platelets
|
November 28, 2006
Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease
Esther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.
Page
of 21